Browse > Article

Bone regenerative effects of recombinant human bone morphogenetic protein-2 employed protein transduction domain  

Jung, Sung-Won (Department of periodontology, Research institute for periodontal Regeneration, College of Dentistry, Yonsei University)
Kim, Nam-Hee (Department of Oral pathology, Oral Cancer Research institute, College of Dentistry, Yonsei University)
Yook, Jong-In (Department of Oral pathology, Oral Cancer Research institute, College of Dentistry, Yonsei University)
Kim, Chang-Sung (Department of periodontology, Research institute for periodontal Regeneration, College of Dentistry, Yonsei University)
Kim, Hyung-Jun (Department of Oral & Maxillofacial surgery, College of Dentistry, Yonsei University)
Cho, Kyoo-Sung (Department of periodontology, Research institute for periodontal Regeneration, College of Dentistry, Yonsei University)
Publication Information
Journal of Periodontal and Implant Science / v.37, no.3, 2007 , pp. 497-509 More about this Journal
Abstract
Bone morphogenetic proteins(BMPs) are regarded as members of the transforming growth $factor-{\beta}$ superfamily with characteristic features in their amino acid sequences. A number of studies have demonstrated the biologic activities of BMPs, which include the induction of cartilage and bone formation. Recently there was a attempt to overcome a limitation of mass production, and economical efficieny of rh-BMPs. The method producing PTD by using bacteria have advantages of acquiry a mass of proteins. Hences, a new treatment which deliver protein employed by protein transduction domain(PTD) has been tried. The purpose of this study was to evaluate the bone regenerative effect of TATBMP-2 and TAT-HA2-BMP-2 employed by PTD from HlV-1 TAT protein for protein translocation in the rat calvarial model. An 8mm calvarial, critical size osteotomy defect was created in each of 32 male Spraque-Dawley rats(weight $250{\sim}300g$). The animals were divided into 4 groups of 32 animals each (4 animals/group/healing interval). The defect was treated with TATBMP-2/ACS(Absorbable collagen sponge) (TATBMP-2 0.1mg/ml), TAT-HA2-BMP-2/ACS(TAT-HA2-BMP-2 0.1mg/ml), ACS alone or left untreated for surgical control(negative control). The rats were sacrificed at 2 or 8 weeks postsurgery, and the results were evaluated histologically. The results were as follows: New bone formation were not significantly greater in the TATBMP-2/ACS group relative to negative, and positive control groups. New bone was evident at the defect sites in TAT-HA2-BMP-2/ACS group relative to negative, positive control and TATBMP-2 groups. There were a little bone regeneration in TATBMP-2 groups. While, enhanced local bone formation were observed in TAT-HA2-BMP-2 group. But, The results was not the same in all rat defects. Therefore, further investigations are required to develop a method. which disperse homogenously, and adhere to target cells.
Keywords
bone regeneration; Bone morphogenetic protein; protein transduction domain;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ahn SH, Kim CS, Suk HJ, et al, Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects. J Periodontol 2003:74:787-797   DOI   ScienceOn
2 Frankel AD, Pabo CO, Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988:55:1189-1193   DOI   ScienceOn
3 Tseng YL, Liu JJ, Hong RL. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. Mol Pharmacal 2002: 62:864-872   DOI   ScienceOn
4 Schmitz JP. Hollinger JO. The critical size defect as an experimental model for eraniomandibulofacial nonunions. Clin Orthop Relat Res 1986:299-308
5 Wang EA, Rosen V, D'Alessandro JS, et al Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990:87:2220-2224
6 Groeneveld EH, Burger EH. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol 2000:142:9-21   DOI
7 Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004; 22:233-241   DOI   ScienceOn
8 Winn SR, Hu Y, Sfeir C, Hollinger JO. Gene therapy approaches for modulating bone regeneration. Adv Drug Deliv Rev 2000:42: 121-138   DOI   ScienceOn
9 Baum BJ. Kok M, Tran SD, Yamano S. The impact of gene therapy on dentistry: a revisiting after six years. J Am Dent Assoc 2002:133:35-44   DOI
10 Griffith DL, Keck PC, Sampath TK, Rueger DC, Carlson WD. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. Proc Natl Acad Sci USA 1996:93:878-883
11 Amano M, Chihara K. Kimura K, et al FormaLion of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 1997; 275 : 1308 -1311   DOI   ScienceOn
12 Lewin M, Carlesso N. Tung CH. et al, Tat peptide-rierivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Bioteclmol 2000: 18:410-414   DOI   ScienceOn
13 Schwarze SR, Hruska KA., Dowdy SF. Protein transduction: unrestricted delivery into all cells? Trends Cell Biol 2000: 10: 290-295   DOI   ScienceOn
14 Celeste AJ, Iannazzi JA. Taylor RC, et al, Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990;87: 9843-9847
15 Sampath TK, Maliakal JC, Hauschka PV, et al, Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and dif- ferentiation in vitro, J Biol Chem 1992:267: 20352-20362   PUBMED
16 Cook SD, Baffes GC. Wolfe MW, et al 3rd. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects, J Bone Joint Surg Am 1994:76:827-838   DOI   PUBMED
17 Cook SD, Salkeld SL, Patron LP. Bone defect healing with an osteogenic protein-1 device combined with carboxymethylcellulose, J Biomed Mater Res B Appl Biomater 2005; 75:137-145   PUBMED
18 Baltzer AW, Lattermann C, Whalen JD, et al, Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 2000:7:734-739   PUBMED
19 King GN, Cochran DL. Factors that modulate the effects of bone morphogenetic protein-induced periodontal regeneration: a critical review. J Periodontol 2002: 73:925-936   DOI   ScienceOn
20 Hong SJ, Kim CS. Han DK, et al, The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects. Biomaterials 2006;27:3810-3816   DOI   ScienceOn
21 Fittipaldi A, Ferrari A, Zoppe M, et al Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J Biol Chem 2003:278:34141-34149   DOI   ScienceOn
22 Choi SH, Kim CK, Cho KS, et al, Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ ACS) on healing in 3-wall in- trabony defects in dogs, J Periodontal 2002;73:63-72   DOI   ScienceOn
23 Park J, Ryu J, Kim KA, et al, Mutational analysis of a human immunodeficiency virus type 1 Tat protein transduction domain which is required for delivery of an exogenous protein into mammalian cells J Gen Viral 2002: 83: 1173-1181   DOI
24 Michiue H, Tomizawa K, Wei FY, et al, The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-rnediated p53 protein transduction, J Biol Chem 2005: 280: 8285-8289   DOI   ScienceOn
25 Wikesjo UM, Guglielmoni P, Promsudthi A, et al, Periodontal repair in dogs: effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol 1999:26:392-400   DOI   ScienceOn
26 Schwarze SR, Dowdy SF, In vivo protein transduction: intracellular delivery of biologically active proteins. compounds and DNA, Trends Pharmacal Sci 2000:21:45-48   DOI   ScienceOn
27 Pang EK, Im SU, Kim CS, et al. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model J Periodontal 2004;75: 1364-1370   DOI   ScienceOn
28 Derossi D, Joliot AH, Chassaing G, Frochiantz A. The third helix of the Antennapedia homeodomain translacates through biological membranes. J Biol Chem 1994: 269: 10444 -10450
29 Gitelman SE, Kobrin MS, Ye JQ, et al, Recombinant Vgr-l/RMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol 1994: 126: 1595-1609   DOI
30 Fawell S, Seery J, Daikh Y, et al Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 1994:91: 664-668
31 Hyun SJ, Han DK, Choi SH, et al Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects, J Periodontal 2005: 76:1667-1674   DOI   ScienceOn
32 Wadia JS, Stan RV, Dowdy SF, Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004:10:310-315   DOI   ScienceOn
33 Han DK, Kim CS, Jung UW, et al Effect of a fibrin-fibroncctin sealing system as a carrier for recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontal 2005: 76: 2216-2222   DOI   ScienceOn
34 Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988: 242: 1528-15:34   DOI
35 Urist MR, Bone: formation by autoinduction, 1965, Clin Orthop Relat Res 2002:4-10
36 Reddi AH. Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am 2001;83-A Suppl 1:S1-6
37 Takagi K, Urist MR. The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann Surg 1982: 196: 100-109   DOI   PUBMED   ScienceOn